Can-Fite BioPharma Ltd. (CANF) Stock on a Slide After a Robust Monday, Here’s Why

Can-Fite BioPharma Ltd. (CANF), a clinical-stage biopharmaceutical company, has plunged 13.49% during the aftermarket trading session. As a result, CANF stock is trading at $1.86 at the time of the writing. The decline could be attributed to the profit-taking factor after CANF rocketed 69.29% during Monday’s regular trading session and closed the day at $2.15. […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.